NASDAQ:LGVN
Longeveron Inc. Stock News
$3.11
+2.77 (+804.86%)
At Close: Mar 27, 2024
Longeveron Inc. (LGVN) Q4 2023 Earnings Call Transcript
09:56pm, Tuesday, 27'th Feb 2024
Longeveron Inc. (LGVN) Q4 2023 Earnings Call Transcript
Longeveron to Report Year-End 2023 Results and Provide Corporate Update February 27, 2024
04:05pm, Wednesday, 21'st Feb 2024
MIAMI, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, a
Longeveron to Report Third Quarter 2023 Results and Provide Corporate Update on November 10, 2023
08:00am, Friday, 03'rd Nov 2023
MIAMI, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for life-threatening and chron
Longeveron stock jumps on Alzheimer's trial results
08:13am, Thursday, 05'th Oct 2023
Longeveron Inc. shares LGVN, +4.58% jumped 16% premarket on Thursday after the clinical-stage biotech company announced positive results from a trial of its Alzheimer's treatment Lomecel-B.
Longeveron to Present at the 25th Annual H.C. Wainwright Global Investment Conference
08:00am, Tuesday, 05'th Sep 2023
MIAMI, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN NASDAQ: LGVNR) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for lif
Longeveron Inc. (LGVN) Q2 2023 Earnings Call Transcript
10:16pm, Friday, 11'th Aug 2023
Longeveron Inc. (NASDAQ:LGVN ) Q2 2023 Earnings Conference Call August 11, 2023 8:00 AM ET Company Participants Mike Moyer - Managing Director, LifeSci Advisors, LLC Wa'el Hashad - Chief Executive Off
Longeveron to Report Second Quarter 2023 Results and Provide Corporate Update on August 11, 2023
08:00am, Monday, 07'th Aug 2023
MIAMI, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for life-threatening and chron
Longeveron Inc. (LGVN) Q1 2023 Earnings Call Transcript
02:14pm, Friday, 12'th May 2023
Longeveron Inc. (NASDAQ:LGVN ) Q1 2023 Earnings Conference Call May 12, 2023 8:30 AM ET Company Participants James Clavijo - Chief Financial Officer Wa'el Hashad - Chief Executive Officer Chris Min -
LGVN Stock Earnings: Longeveron Misses EPS, Revenue Estimates
08:32am, Friday, 12'th May 2023
Longeveron (NASDAQ: LGVN ) just reported results for the first quarter of 2023. Longeveron reported a loss per share of 22 cents.
Why Is Longeveron (LGVN) Stock Up 30% Today?
10:42am, Tuesday, 09'th May 2023
Longeveron (NASDAQ: LGVN ) stock is on the move Tuesday after releasing long-term survival data from its HLHS treatment. According to the company, all 10 patients that received Lomecel-B during their
Longeveron stock up 15.5% premarket after positive results in trial of treatment for rare congenital heart defect in infants
08:41am, Tuesday, 09'th May 2023
Longeveron Inc.'s stock LGVN rocketed 15.5% in premarket trade Tuesday, after the biotech said its Lomecel-B for the treatment of a congenital heart defect in infants (Hypoplastic Left Heart Syndrome)
Longeveron to Announce First Quarter 2023 Financial Results on May 12, 2023
08:30am, Monday, 08'th May 2023
MIAMI, May 08, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, to
Longeveron Inc. (LGVN) Q4 2022 Earnings Call Transcript
06:40pm, Friday, 10'th Mar 2023
Longeveron Inc. (NASDAQ:LGVN ) Q4 2022 Results Conference Call March 10, 2023 8:30 AM ET Company Participants James Clavijo - CFO Wa'el Hashad - CEO Dr. Chris Min - Chief Medical Officer Conference Ca
Longeveron to Announce Fourth Quarter and Full Year Financial Results on March 10, 2023
08:30am, Monday, 06'th Mar 2023
Live conference call on Friday, March 10 at 8:30 a.m. ET Live conference call on Friday, March 10 at 8:30 a.m. ET
3 Penny Stocks That Could Rise 500% in 2023
11:37am, Friday, 13'th Jan 2023
In November 2021, I made an outlandish effort to pick 5 cheap stocks that could double within a month. Few companies rise 100%, and even fewer can do it in the time it takes to properly pickle a cucum